PubRank

B Sis

Author PubWeight™ 68.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008 8.09
2 Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 5.39
3 Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2011 4.06
4 Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009 3.43
5 Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014 3.43
6 Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012 2.28
7 Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007 2.25
8 De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009 2.24
9 FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008 1.94
10 NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 2010 1.62
11 The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant 2011 1.60
12 Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant 2013 1.57
13 The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant 2010 1.54
14 The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant 2010 1.43
15 Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008 1.27
16 Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 2013 1.25
17 Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant 2009 1.21
18 Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant 2009 1.19
19 An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am J Transplant 2010 1.16
20 Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant 2011 1.16
21 The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 2007 1.13
22 Comparing microarray versus RT-PCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges. Am J Transplant 2008 1.10
23 SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 2007 1.10
24 Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm. Am J Transplant 2008 1.06
25 Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 2012 1.06
26 Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant 2008 1.02
27 The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants. Am J Transplant 2008 1.01
28 Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. Am J Transplant 2007 0.96
29 Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts. Am J Transplant 2008 0.95
30 Early loss of renal transcripts in kidney allografts: relationship to the development of histologic lesions and alloimmune effector mechanisms. Am J Transplant 2007 0.93
31 The molecular phenotype of kidney transplants. Am J Transplant 2010 0.92
32 Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder? Urology 2001 0.92
33 Loss of solute carriers in T cell-mediated rejection in mouse and human kidneys: an active epithelial injury-repair response. Am J Transplant 2010 0.91
34 Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant 2010 0.90
35 Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. Pathol Res Pract 2001 0.83
36 BRCA1, C-erbB-2, and H-ras gene expressions in young women with breast cancer. An immunohistochemical study. Appl Immunohistochem Mol Morphol 2000 0.82
37 Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B. Am J Transplant 2006 0.81
38 Alternative macrophage activation-associated transcripts in T-cell-mediated rejection of mouse kidney allografts. Am J Transplant 2010 0.81
39 Expression of pS2 protein and its relation with the Ki-67 proliferative indices and tumor recurrence in superficial bladder carcinomas. Eur Urol 2001 0.80
40 VSL#3 probiotics provide protection against acute intestinal ischaemia/reperfusion injury. Benef Microbes 2013 0.78
41 An appeal for zero-time biopsies in renal transplantation. Am J Transplant 2008 0.77
42 Tubular CD44 expression in renal allograft biopsies. Transplant Proc 2004 0.76
43 Osseous and myeloid metaplasia in a failed renal allograft. Kidney Int 2007 0.75
44 Donor Fas is not necessary for T-cell-mediated rejection of mouse kidney allografts. Am J Transplant 2008 0.75
45 Histologic findings from positive crossmatch or ABO-incompatible renal allografts: accomodation or chronic allograft injury? Am J Transplant 2006 0.75
46 Quantitative digital histochemistry with methenamine silver staining in renal allograft biopsies excluding pure chronic allograft nephropathy cases. Transplant Proc 2006 0.75